V

VistaGen Therapeutics
D

VTGN

2.93000
USD
0.09
(3.17%)
مغلق
حجم التداول
5,824
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
84,565,909
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    AGEN
    -0.11500
    (-3.34%)
    3.33000 USD
    C
    CRVS
    -0.22000
    (-4.99%)
    4.19000 USD
    G
    GERN
    -0.05500
    (-2.10%)
    2.57000 USD
    P
    PTN
    -0.02500
    (-2.43%)
    1.00500 USD
    V
    VRNA
    3.850
    (6.00%)
    68.020 USD
    المزيد
الأخبار
المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.